Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07519473

Neuromuscular Versus Resistance Training on Functional Capacity in Patients With Heart Failure.

This randomized controlled trial will compare the effects of neuromuscular training and resistance training on functional capacity, cardiorespiratory fitness, and lower limb performance in patients with chronic heart failure. A total of 40 participants will be randomly assigned into two groups in a single-blinded design.

Both groups will undergo a 10-week supervised exercise program. Outcomes will be assessed using VO₂ peak, 6-Minute Walk Test (6MWT), Short Physical Performance Battery (SPPB), and quality of life measures.

The study aims to determine the more effective rehabilitation approach for improving clinical outcomes in heart failure patients.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

40 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

community based Cardiac Rehab Unit, Cardiac Centers, and Tertiary Care Hospitals

Lahore, Punjab Province, 40100, Pakistan

Location contact

Arjumand bano, MS-CPPT

CONTACT

[email protected]

03059551883

syeda Fizza Kazmi, MS-CPPT

PRINCIPAL_INVESTIGATOR

About this study

Heart failure is a chronic and progressive condition associated with reduced functional capacity, impaired cardiorespiratory fitness, and decreased lower limb performance, significantly affecting quality of life. Exercise-based cardiac rehabilitation is an established intervention; however, the comparative effectiveness of different exercise modalities, particularly neuromuscular training and resistance training, remains insufficiently explored.

This study is a single-blinded randomized controlled trial designed to compare the effects of neuromuscular training and resistance training on functional capacity, cardiorespiratory fitness, and lower limb performance in patients with chronic heart failure. A total of 40 participants meeting the inclusion criteria will be recruited from tertiary care hospitals and cardiac rehabilitation centers. After baseline assessment, participants will be randomly allocated into two groups using a concealed allocation method.

Both groups will undergo a supervised 10-week intervention program consisting of 20 sessions (2 sessions per week). Each session will include warm-up, 20 minutes of specific training, 20 minutes of moderate-intensity aerobic exercise, and cool-down. The resistance training group will perform exercises targeting major muscle groups at moderate intensity (50-70% of one-repetition maximum), while the neuromuscular training group will focus on balance, coordination, proprioception, and motor control using structured functional exercises.

Primary outcome measures will include cardiorespiratory fitness (VO₂ peak assessed via Chester Step Test), functional capacity (6-Minute Walk Test), and lower limb performance (Short Physical Performance Battery). Secondary outcomes will include resting heart rate, blood pressure, oxygen saturation, perceived exertion (Borg CR-10), and quality of life measured using the Kansas City Cardiomyopathy Questionnaire (KCCQ).

Assessments will be conducted at baseline and after completion of the intervention by a blinded assessor to minimize bias. Data will be analyzed using appropriate statistical methods to compare within-group and between-group differences.

This study aims to generate evidence on the comparative effectiveness of neuromuscular and resistance training, which may help in optimizing cardiac rehabilitation protocols and improving clinical outcomes in patients with heart failure.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male and female patients aged 40-60 years
  • Diagnosed with chronic heart failure ≥ 1 year
  • Heart failure with reduced ejection fraction (HFrEF), EF ≤ 40%
  • NYHA Class II-III
  • Low to moderate exercise risk (based on Chester Step Test)
  • On stable pharmacological treatment for ≥ 6 weeks
  • Able to understand and follow exercise instructions

Exclusion criteria

  • Absolute contraindications to exercise (e.g., recent MI, unstable angina, uncontrolled arrhythmias, severe aortic stenosis, decompensated HF)
  • Abnormal CPET findings (severe arrhythmias, ischemia, ST depression)
  • Abnormal blood pressure response during exercise
  • Exercise-induced angina or thoracic pain
  • Musculoskeletal, neurological, or cognitive impairments limiting exercise participation

Treatment and study plan

Resistance training

Behavioral

A supervised resistance training program targeting major muscle groups using resistance bands, machines, and bodyweight exercises. Training intensity will be set at 50-70% of one-repetition maximum and progressed based on patient tolerance. Each session will include warm-up, 20 minutes of resistance exercises, 20 minutes of moderate-intensity aerobic exercise, and cool-down. Sessions will be conducted twice weekly for 10 weeks.

Other names: Strength Training; Exercise Therapy

Neuromuscular training

Behavioral

A supervised neuromuscular training program focusing on balance, coordination, proprioception, and postural control. Exercises will include dynamic balance tasks, limb coordination, and training on unstable surfaces. Each session will include warm-up, 20 minutes of neuromuscular exercises, 20 minutes of moderate-intensity aerobic exercise, and cool-down. Sessions will be conducted twice weekly for 10 weeks.

Other names: Balance Training; Proprioceptive Training; Motor Control Training

Primary outcomes

  1. Functional Capacity

    Time frame: Baseline and after 10 weeks of intervention

    Functional capacity will be assessed using the Six-Minute Walk Test (6MWT), which measures the distance a participant can walk on a flat surface in 6 minutes. It is a validated and reliable measure used in cardiac rehabilitation to evaluate exercise tolerance and daily functional ability in patients with heart failure.

  2. Cardiorespiratory Fitness (VO₂ Peak)

    Time frame: Baseline and after 10 weeks of intervention

    Cardiorespiratory fitness will be assessed using the Chester Step Test, which estimates VO₂ peak based on heart rate response during graded stepping exercise. VO₂ peak is a key indicator of aerobic capacity and cardiovascular health in patients with heart failure.

  3. Lower Limb Performance

    Time frame: Baseline and after 10 weeks of intervention

    Lower limb performance will be assessed using the Short Physical Performance Battery (SPPB), which includes balance tests, gait speed, and chair stand tests. It is a validated tool for assessing lower extremity function in clinical populations.

Study contacts

Contact information is provided by the study sponsor or research team.

Muhammad Iqbal Tariq, Phd*

CONTACT

[email protected]

03338236752

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Official study title

Comparative Effects Between Neuromuscular Versus Resistance Training on Functional Capacity, Cardiorespiratory Fitness, and Lower Limb Performance in Patients With Heart Failure.

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Apr 9, 2026
Registry last updated
Apr 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.